Sage Therapeutic Stock Forecast - Naive Prediction

SAGE Stock  USD 5.00  0.03  0.60%   
The Naive Prediction forecasted value of Sage Therapeutic on the next trading day is expected to be 3.91 with a mean absolute deviation of 0.34 and the sum of the absolute errors of 21.33. Sage Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Sage Therapeutic stock prices and determine the direction of Sage Therapeutic's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Sage Therapeutic's historical fundamentals, such as revenue growth or operating cash flow patterns.
  
At present, Sage Therapeutic's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Receivables Turnover is expected to grow to 1.08, whereas Fixed Asset Turnover is forecasted to decline to 11.17. . As of December 20, 2024, Common Stock Shares Outstanding is expected to decline to about 45.7 M. The current year's Net Loss is expected to grow to about (455.5 M).

Sage Therapeutic Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Sage Therapeutic's financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2012-12-31
Previous Quarter
101.2 M
Current Value
99.6 M
Quarterly Volatility
265.2 M
 
Yuan Drop
 
Covid
A naive forecasting model for Sage Therapeutic is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Sage Therapeutic value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Sage Therapeutic Naive Prediction Price Forecast For the 21st of December

Given 90 days horizon, the Naive Prediction forecasted value of Sage Therapeutic on the next trading day is expected to be 3.91 with a mean absolute deviation of 0.34, mean absolute percentage error of 0.19, and the sum of the absolute errors of 21.33.
Please note that although there have been many attempts to predict Sage Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Sage Therapeutic's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Sage Therapeutic Stock Forecast Pattern

Backtest Sage TherapeuticSage Therapeutic Price PredictionBuy or Sell Advice 

Sage Therapeutic Forecasted Value

In the context of forecasting Sage Therapeutic's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Sage Therapeutic's downside and upside margins for the forecasting period are 0.05 and 8.62, respectively. We have considered Sage Therapeutic's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
5.00
3.91
Expected Value
8.62
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Sage Therapeutic stock data series using in forecasting. Note that when a statistical model is used to represent Sage Therapeutic stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria118.2957
BiasArithmetic mean of the errors None
MADMean absolute deviation0.344
MAPEMean absolute percentage error0.0543
SAESum of the absolute errors21.3287
This model is not at all useful as a medium-long range forecasting tool of Sage Therapeutic. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Sage Therapeutic. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Sage Therapeutic

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Sage Therapeutic. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.315.009.69
Details
Intrinsic
Valuation
LowRealHigh
0.234.559.24
Details
20 Analysts
Consensus
LowTargetHigh
23.4025.7128.54
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.71-1.62-1.49
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Sage Therapeutic. Your research has to be compared to or analyzed against Sage Therapeutic's peers to derive any actionable benefits. When done correctly, Sage Therapeutic's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Sage Therapeutic.

Other Forecasting Options for Sage Therapeutic

For every potential investor in Sage, whether a beginner or expert, Sage Therapeutic's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Sage Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Sage. Basic forecasting techniques help filter out the noise by identifying Sage Therapeutic's price trends.

View Sage Therapeutic Related Equities

 Risk & Return  Correlation

Sage Therapeutic Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Sage Therapeutic's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Sage Therapeutic's current price.

Sage Therapeutic Market Strength Events

Market strength indicators help investors to evaluate how Sage Therapeutic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sage Therapeutic shares will generate the highest return on investment. By undertsting and applying Sage Therapeutic stock market strength indicators, traders can identify Sage Therapeutic entry and exit signals to maximize returns.

Sage Therapeutic Risk Indicators

The analysis of Sage Therapeutic's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Sage Therapeutic's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting sage stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sage Therapeutic is a strong investment it is important to analyze Sage Therapeutic's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Sage Therapeutic's future performance. For an informed investment choice regarding Sage Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Sage Therapeutic to cross-verify your projections.
For information on how to trade Sage Stock refer to our How to Trade Sage Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sage Therapeutic. If investors know Sage will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sage Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.57)
Revenue Per Share
1.76
Quarterly Revenue Growth
3.371
Return On Assets
(0.30)
Return On Equity
(0.49)
The market value of Sage Therapeutic is measured differently than its book value, which is the value of Sage that is recorded on the company's balance sheet. Investors also form their own opinion of Sage Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Sage Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sage Therapeutic's market value can be influenced by many factors that don't directly affect Sage Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sage Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sage Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sage Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.